206 related articles for article (PubMed ID: 23595049)
21. Renal denervation for hypertension.
Bertog SC; Sobotka PA; Sievert H
JACC Cardiovasc Interv; 2012 Mar; 5(3):249-58. PubMed ID: 22440489
[TBL] [Abstract][Full Text] [Related]
22. Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation.
Tank J; Heusser K; Brinkmann J; Schmidt BM; Menne J; Bauersachs J; Haller H; Diedrich A; Jordan J
J Am Soc Hypertens; 2015 Oct; 9(10):794-801. PubMed ID: 26324745
[TBL] [Abstract][Full Text] [Related]
23. Expanding the indication spectrum: renal denervation in diabetes.
Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology I: the kidney and the sympathetic nervous system.
de Jager RL; Blankestijn PJ
EuroIntervention; 2013 May; 9 Suppl R():R42-7. PubMed ID: 23732154
[TBL] [Abstract][Full Text] [Related]
25. Unilateral renal artery sympathetic denervation may reduce blood pressure in patients with resistant hypertension.
Armaganijan L; Staico R; Abizaid A; Moraes A; Moreira D; Amodeo C; Sousa M; Sousa JE
J Clin Hypertens (Greenwich); 2013 Aug; 15(8):606. PubMed ID: 23889725
[No Abstract] [Full Text] [Related]
26. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Duval J; Lee R; Sata Y; Krum H; Lambert E; Peter K; Head G; Lambert G; Esler MD; Schlaich MP
Int J Cardiol; 2016 Jan; 202():388-93. PubMed ID: 26432488
[TBL] [Abstract][Full Text] [Related]
27. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.
Brinkmann J; Heusser K; Schmidt BM; Menne J; Klein G; Bauersachs J; Haller H; Sweep FC; Diedrich A; Jordan J; Tank J
Hypertension; 2012 Dec; 60(6):1485-90. PubMed ID: 23045466
[TBL] [Abstract][Full Text] [Related]
28. [Renal denervation - a novel therapeutic option for resistant hypertension?].
Ritter A; Sudano Noll I; Suter PM
Praxis (Bern 1994); 2014 Oct; 103(20):1169-78. PubMed ID: 25270745
[No Abstract] [Full Text] [Related]
29. Current technologies: an introduction.
Daemen J
EuroIntervention; 2013 May; 9 Suppl R():R75-82. PubMed ID: 23732160
[No Abstract] [Full Text] [Related]
30. Challenging anatomy, how to treat or not to treat?
Zeller T; Rastan A; Macharzina R; Noory E
EuroIntervention; 2013 May; 9 Suppl R():R67-74. PubMed ID: 23732158
[TBL] [Abstract][Full Text] [Related]
31. Renal denervation: the Irish experience.
Kyvelou SM; Sharif F; Tuohy S; Jatoi NA; Vlachopoulos C; Stefanadis C
Hellenic J Cardiol; 2013; 54(6):486-7. PubMed ID: 24305589
[No Abstract] [Full Text] [Related]
32. Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension.
Ewen S; Mahfoud F; Linz D; Pöss J; Cremers B; Kindermann I; Laufs U; Ukena C; Böhm M
Hypertension; 2014 Apr; 63(4):839-45. PubMed ID: 24420550
[TBL] [Abstract][Full Text] [Related]
33. Acute Vasodilation Caused by Different Strategies of Renal Sympathetic Denervation for Right and Left Renal Arteries.
Kiuchi MG; Chen S; Hoye NA
Ann Vasc Surg; 2017 Jan; 38():345-347. PubMed ID: 27666799
[No Abstract] [Full Text] [Related]
34. Renal denervation: what next?
Joyner MJ
Hypertension; 2014 Jul; 64(1):19-20. PubMed ID: 24732888
[No Abstract] [Full Text] [Related]
35. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
[TBL] [Abstract][Full Text] [Related]
36. Renal denervation using an irrigated radiofrequency ablation catheter for management of drug-resistant hypertension: a demonstrated value?
Frohlich ED
JACC Cardiovasc Interv; 2012 Jul; 5(7):766-8. PubMed ID: 22814782
[No Abstract] [Full Text] [Related]
37. [Radiofrequency sympathetic renal denervation: a new version of the old method of treatment resistant hypertension].
Shavarov AA; Maĭskov VV; Kobalava ZhD
Kardiologiia; 2013; 53(1):72-8. PubMed ID: 23548354
[No Abstract] [Full Text] [Related]
38. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation.
Wang Y
Int J Cardiol; 2014 Oct; 176(3):1262-3. PubMed ID: 25115259
[No Abstract] [Full Text] [Related]
39. Renal denervation in the era of HTN-3. Comprehensive review and glimpse into the future.
Silva JD; Costa M; Gersh BJ; Gonçalves L
J Am Soc Hypertens; 2016 Aug; 10(8):656-70. PubMed ID: 27319336
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous renal denervation: new treatment option for resistant hypertension and more?
Ewen S; Ukena C; Böhm M; Mahfoud F
Heart; 2013 Aug; 99(15):1129-34. PubMed ID: 23418204
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
